Navigation Links
ESC events in Asia tackle management of diabetes and cardiovascular disease
Date:10/30/2009

last year's inaugural event, a second ESC Asia Cardiovascular Symposium was held in Beijing on 12 September. The one-day programme provided an opportunity for leading physicians from Asian countries to examine CVD risk factors and discuss management of an increasing precedence of the disease - attributed to westernisation of diet and lifestyle. The first ESC Asia Cardiovascular Symposium in Shanghai in September 2008 aimed to raise awareness of the growing burden of CVD in the AP region, and the need for screening and risk assessment tools for early detection and intervention.

The second symposium set out to take the next step by:

  • defining effective pharmacological management of hypertension, diabetes and the risk of thrombosis in the AP region.
  • translating clinical practice guidelines into reality in local practice.
  • underlining the importance of informing primary care physicians of current guidelines and to practise accordingly.
  • considering similarities and differences between East and West in the prevention and treatment of CVD.
  • providing an opportunity to exchange information and experience.

The September symposium was co-chaired by three experts in the fields of cardiovascular medicine: Professor Lars Rydn (Sweden) representing the ESC, Professor Lim Yean Teng (Singapore) and Professor Yong Huo (China). For the attending delegates, who came from all over AP and represented a number of specialties, the programme provided an opportunity to look at a multifactorial approach to CVD risk management. Using patient case studies, speakers demonstrated how lifestyle modification often has to be supplemented by pharmacotherapy. Panel discussions raised important issues such as the need to proactively manage patients with atrial fibrillation, who are at increased risk of stroke. There was agreement among the disciplines that intervention per se should be based on total cardiovascular risk, but that each of the contributi
'/>"/>

Contact: ESC Press Office
press@escardio.org
33-049-294-8627
European Society of Cardiology
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Hogs n Hens for Hope NCPC BBQ Cook-Off & Festival October 17 at Duplin County Events Center Features Fun for the Whole Family and Benefits Lazarex Cancer Foundation
2. Asbestos Trusts, Asbestos Judges Featured at Two HB Events Dec. 2 & 3
3. First-Ever Christopher Reeve Day (9/25/09) to be Celebrated with Memorable Chicago Events
4. Radware Prevents Network Downtime for Carolinas HealthCare System, One of the Largest Healthcare Systems in the U.S.
5. Womens Dermatologic Society Volunteers Make Huge Impact at Four Sun Safety Events in August
6. 12th Annual Henry Schein Back-to-School Events Help 2,000 Underserved Children Return to the Classroom in Style
7. Research Demonstrates that HerbalSciences Proprietary Elderberry Extract Prevents in Vitro H1N1 Influenza Infection
8. RCN Hosts Blood Drives and Events with Appearances by HBO Hit Series True Blood, Nelsan Ellis
9. Stuy in NEJM: New therapy prevents heart failure
10. Gene Fix in Egg Prevents Inherited Diseases in Monkeys
11. Nurses to Benefit From New CMS Never Events Resource Area on Mosbys Nursing Consult

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)... Ennis & Ennis, P.A. is offering free nationwi... Yasmin birth control pills who have suffered a De...ke, Heart Attack or other related cardiac issues o...ll free at 1-800-856-6405 or go to the firm’...t an online case evaluation form. , ...
(Date:11/25/2009)...,Nov.25/PRNewswire/-SentinelleMedicalInc.,aleading...dsoftwareandCalgaryScientificInc.,aleadingprovider...ersionofAegis(TM)Breast4DAdvancedVisualizationsoft...zero-footprintWebclientbasedmedicalimagingoffering...allowsforzero-footprintaccess-requiringnosoftwared...
(Date:11/25/2009).../PRNewswire-USNewswire/--TheBlackAIDSInstituterece...veleadershipfor2010. ,, ThenewBoardMembersareah...olicy,law,finance,governmenthealthprograms,editori...omawiderangeofpersonalbackgroundsincludingbothhete...emselves,andrepresentingmultipleagegroups. ,, (...
(Date:11/25/2009)...evidence of a statistically significant survival b...e estrogen receptor (ER)-positive tumors had high ...18 (ER-alpha S118-P), according to a brief communi...l of the National Cancer Institute . , Approxima...oxifen. Preclinical studies have shown that ER-alp...
(Date:11/25/2009)...o fight rheumatoid arthritis, could help newly dia...DAY, Nov. 25 (HealthDay News) -- A drug commonly u... arthritis now also shows some promise in helping ..., The drug, rituximab (Rituxan), helped patients k...gh the disease had destroyed some of their pancrea...
Breaking Medicine News(10 mins):Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3
... studies on subject, researchers note , , ...been enough studies to tell whether aspirin reduce...th the blocked leg blood vessel condition called p...studies of aspirin use with peripheral arterial di...
...ear-old Alexander, it,s meant orthotics and physic... For 7-year-old Rebecca, it,s an insulin pump for ...o has cerebral palsy, it,s a wheelchair. , , All ... help pay for desperately needed medical care or e...
...e More Informed Decisions When Choosing Nutritiona...ews stories on steroid use in sports continue to e...ements and sports nutrition products for banned su...o protecting and improving public health, has laun...
...s and experts will gather in New Orleans on June 1...ealth and property damage controversy involving bu...hey also are gathering for two teleconferences dea...least 13 states and the District of Columbia have ...
... posed by other strains of influenza, CDC says , ...health officials said Tuesday that they,re seeing ...ne flu continues to spread across the country. , "... severe complications in women with this year,s no...
...sTek, the leader in innovative electronic patient ...tion for clinical trials has continued its investm...ssisTek,s ongoing development of Smart Phone and e...9 -- assisTek, the leader in innovative electroni...
Other Medicine News:Health News:Aspirin Lowers Stroke Risk in Peripheral Artery Disease 2Health News:Aspirin Lowers Stroke Risk in Peripheral Artery Disease 3Health News:UnitedHealthcare Children's Foundation To Award More Medical Grants for Child Health Care Needs in New Jersey 2Health News:New Online Resource for Consumers, Athletes and Coaches Concerned About Athletic Banned Substances 2Health News:Chinese Drywall Litigation Subject of Conference and Two Teleconferences 2Health News:Swine Flu May Pose Problems for Pregnant Women 2Health News:Swine Flu May Pose Problems for Pregnant Women 3Health News:Swine Flu May Pose Problems for Pregnant Women 4Health News:Swine Flu May Pose Problems for Pregnant Women 5Health News:Swine Flu May Pose Problems for Pregnant Women 6Health News:Swine Flu May Pose Problems for Pregnant Women 7Health News:Swine Flu May Pose Problems for Pregnant Women 8Health News:Swine Flu May Pose Problems for Pregnant Women 9Health News:Smart Phone, ePRO, and eDiary Technology Advances for Clinical Trials, Market Research, and Registries Reported by assisTek 2Health News:Smart Phone, ePRO, and eDiary Technology Advances for Clinical Trials, Market Research, and Registries Reported by assisTek 3
(Date:11/24/2009)...REMONT,Calif.,Nov.24/PRNewswire-FirstCall/--Vermil...nyfileditsPlanofReorganizationandDisclosureStateme...tcyCourtfortheDistrictofDelaware.Ahearingtoconside...ledforDecember8,2009,withthehearingontheconfirmati...ncallsfortheCompanytopayallclaimsinfull.ThePlanise...
(Date:11/24/2009)...OODCLIFFLAKE,N.J.andNEWYORK,Nov.24/PRNewswire/-- ...andDrugAdministration(FDA)hasacceptedforreviewEisa...#174;(donepezilHClextendedrelease)tabletsforthetre...snewhigherdoseformulationcontains23mgofdonepezilHC...ysystemthatallowsforgradualreleaseofthedrug.TheNDA...
(Date:11/24/2009)...LEASANTON,Calif.,Nov.24/PRNewswire-FirstCall/--Tho...ce-basedmechanicalcirculatorysupporttherapiestosav...llbeparticipatinginthe21stAnnualPiperJaffrayHealth...ith,executivevicepresidentandchieffinancialofficer...m.,EasternStandardTime(5:30a.m.,PacificStandardTim...
Breaking Medicine Technology:Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 3Curemark Announces Senior Executive Promotions 5301 1Curemark Announces Senior Executive Promotions 5301 2Curemark Announces Senior Executive Promotions 5301 3Lab on a Chip Might Speed Breast Cancer Monitoring 59092 1Lab on a Chip Might Speed Breast Cancer Monitoring 59092 2Lab on a Chip Might Speed Breast Cancer Monitoring 59092 3Potential Pieces of Autism Puzzle Revealed 59089 1Potential Pieces of Autism Puzzle Revealed 59089 2
...EY HEIGHTS, NJ – June 4, 2007 – Genta,...tion of results,from a Phase 2 clinical trial of i...injection), plus rituximab (Rituxan®;,Genentec...d or,refractory non-Hodgkin’s lymphoma (NHL)... the American Society of Clinical,Oncology (ASCO) ...
...O--(BUSINESS WIRE)--Jun 4, 2007 - Introgen Therape...cal collaborators today,reported updated Phase 2 d...n abnormal p53, tumor responses and increased,surv... recurrent,squamous cell carcinoma of the head and...day at the annual meeting of the American,Society ...
Other Medicine Technology:Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 2Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 3Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 4Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 5Introgen Reports Updated Phase 2 Advexin Data Correlating Improved,Survival, Tumor Responses and Predictive p53 Biomarker 2Introgen Reports Updated Phase 2 Advexin Data Correlating Improved,Survival, Tumor Responses and Predictive p53 Biomarker 3Introgen Reports Updated Phase 2 Advexin Data Correlating Improved,Survival, Tumor Responses and Predictive p53 Biomarker 4
LabDAQ3 Laboratory Information System
...ies to work more efficiently has never been higher...th the COBAS INTEGRA® 400 plus, innovation mea...ndling of reaction cuvettes and improved operator ...ease-of-use required for true workload consolidati...
...ng a non-contact diagnostic lens, doctors have to ...gh magnification. Now, with the Digital Wide Fiel...n have both in one lens. This lens provides the w...s paired with the higher magnification required fo...
...Anchor is a unique double loaded anchor perfect fo...y-L Lactic Acid (PLLA) and comes in two sizes: 5.0...nds for open repairs, and can easily be cut-off fo...lows insertion with minimal procedural steps and t...
Medicine Products: